Team:Imperial College London/M2/EncapsulationRationale

From 2009.igem.org

Revision as of 20:23, 6 October 2009 by Tywang (Talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)



Encapsulation Rationale

In nature, encapsulation pathways such as spore formation, aliginate biosynthesis and colanic acid production all share one common feature: they require a large number of genes. For this reason, we decided that the best way encapsulate our chassis was via the modulation of an existing pathway.

E.coli naturally produces a harmless acid resistant polymer known as colanic acid. By tapping into the pathway that initiates colanic acid biosynthesis, we can turn on its production via the modulation of a gene called RcsB.

In nature, colanic acid acts as a binding agent between individual cells over which a biofilm can be formed. While colanic acid itself is harmless, biofilm formation is associated with the production of a number of virulence factors. To prevent biofilm formation from occuring, we have tapped into a second pathway such that our cells become locked into colanic acid production. The gene responsible for preventing biofilm formation is a transcription factor called YgiV.

In nature, colanic acid is associated with but not attached to the cell surface. To facilitate whole cell encapsulation, we have modified a third pathway to fix the colanic acid to the surface of the cell. This involves an enzyme called Rfal.




  About RcsB, YgiV and Rfal.




Module 2 - Encapsulation

Genetic Circuit
WetLab
Modelling
Results

Mr. Gene   Geneart   Clontech   Giant Microbes